A new fiber product called Bellway has generated interest from the investment community as it presents a new take on an old standby—psyllium seed husk.
A New York-based contract manufacturer has recalled hundreds of lines of products manufactured over a period of almost seven years in a consent decree it publicized recently.
Weight management continues to be a category that drives the supplement industry. A webinar on Jan 29 that features a host of expert speakers will examine the latest trends in this category.
A call from FDA to consumers to avoid products recalled as part of an enforcement action underscores how difficult it can be to get offending articles off the market.
The dietary supplement industry is a crazy quilt that marries the sublime to the ridiculous and includes players of the highest moral and intellectual standards as well as those participating in the basest grubbing for money.
Encapsulation methods can skew test results if they are not properly accounted for in ingredients and/or finished product testing, a supplier cautions.
The growing obesity epidemic has flummoxed public health officials. Unfortunately, the dietary supplement industry has a checkered history in helping to find solutions.
A recent appellate court decision coupled with a spate of warning letters sets the stage for more class action lawsuits like the proposed ones filed against CBD companies this week, experts say.
Europe’s Food Safety Authority (EFSA) rules scientific evidence pointing to a white kidney bean extract’s link with body weight reduction as “insufficient,” after the applicant cites application process inconsistencies.
Historically, our healthcare system has been focused on sick care. One expert wants to put the spotlight on polypharmacology, a lesser-known technique used in well care.
The turmoil surrounding the CBD question has obscured other important debates, such as how to alter DHSEA is such a way that more scientific information can be conveyed to consumers.
An expert panel has recommended an expanded treatment envelope for the EPA drug Vascepa. An expert says the move won’t affect the supplement market directly but does add to recent official recognition of the health benefits of omega-3s.
